| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |